Possible prognostic markers for predicting recurrent and persistent thyroid cancers and guiding therapy include tumor size > 3 cm, lymphovascular invasion, vascular invasion, extrathyroidal extension, response to primary therapy, and the proliferative index Ki‐67. This evidence concerns the gene MKI67 and thyroid gland carcinoma.